Distribution of the type I interferon in different organs of chicken digestive system

Central European Journal of Immunology

Volumn 39, Issue 4, 2014, Pages 455-460

  Guo, Shu Yuan ^a   Li, Chao ^a   Dai, Xiu Mei ^a   Zhao, Cui ^a   Chang, Wei Shan ^a  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Interferon antiviral activity; Interferon receptor; Oral interferon; Relative fluorescence quantitative PCR

Indexed keywords

ALPHA1 INTERFERON; BETA ACTIN; INTERFERON RECEPTOR; PEPSIN A; SODIUM CHLORIDE; TRYPSIN;

ACIDITY; ALKALINITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CLONING; CONTROLLED STUDY; CRAW; DIGESTIVE SYSTEM; DUODENUM; ESOPHAGUS; FLUORESCENCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GLANDULAR STOMACH; JUNGLE FOWL; MOLECULAR CLONING; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN; PALATE; PHYSICAL CHEMISTRY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECTUM; STOMACH; TONGUE;

EID: 84919420246     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2014.47728     Document Type: Article

References (18)

1. Isaacs A, Lindenmann J (1957): Viral interference I. The interferon. Proc R Soc Lond B Biol Sci 147: 258-267.
2. Pestka S, Krause CD, Walter MR (2004): Interferons, inter-feron-like cytokines, and their receptors. Immunol Rev 202: 8-32.
3. Kotenko SV, Gallagher G, Baurin V.V., et al. (2003): IFN-lambdas mediate antivira l protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
4. de Veer MJ, Holko M, Frevel M., et al. (2001): Functional classication of interferon-stimulated genes identied using mi-croarrays. J Leukoc Biol 69: 912-920.
5. Takaoka A, Hayakawa S, Yanai H., et al. (2003): Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516-523.
6. de Weerd NA, Nguyen T (2012): The interferons and their receptors - distribution and regulation. Immunol Cell Biol 90: 483-491.
7. Piehler J, Thomas C, Garcia K.C., Schreiber G (2012): Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation. Immunol Rev 250: 317-334.
8. Mogensen KE, Lewerenz M, Reboul J., et al. (1999): The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 19: 1069-1098.
9. Wu Ying-hong, Wang Xue-li, Duan Xiao-yu, Li Xiang-yang, Li Yang-hong, Sun Xiao-ping, Wang Wei, Lu Yan-hua (2007): Progress in the study of interferon. J Inner Mongolia University for Nationalities (Natural Sciences) 4: 425-428.
10. Carter WA, Strayer DR. Broad spectrum immune and antiviral gene modulation by oral interferon: U.S. Patent 8,075,877 [P]. 2011-12-13.
11. Tekwe CD, Lei J, Yao K (2013): Oral administration of interferon tau enhances oxidation of energy substrates and reduces adiposity in Zucker diabetic fatty rats. BioFactors 39: 552-563.
12. Cohen JA, Barkhof F, Comi G (2009): Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362: 402-415.
13. Marcus PI, van der Heide L, Sekellick MJ (1999): Interferon action on avian viruses. I. Oral administration of chicken interferon-alpha ameliorates Newcastle disease. J Interferon Cytokine Res 19: 881-885.
14. Kozlowski A, Harris JM (2001): Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C. J Control Release 72: 217-224.
15. Giannelli G, Antonelli G, Fera G., et al. (1994): Biological and clinical significance of neutralizing and binding antibodies to IFN-α during therapy for chronic hepatitis C. Clin Exp Immunol 97: 4-9.
16. Schwarz AM, Banning-Eichenseer U, Seidel K., et al. (2013): Impact of interleukin-10 on phenotype and gene expression during early monocyte differentiation into dendritic cells. Anticancer Res 33: 4791-4798.
17. Iyer SS, Cheng G (2012): Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32: 23-63.
18. Boyman O, Sprent J (2012): The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12: 180-190.